Nathan J. Dowden, Chief Operating Officer at Entrada Therapeutics, Inc. (TRDA), sold 17,796 shares at $20.97 ($369K) on 2022-10-25, disclosed to the SEC on 2022-10-27.
Open-market sale of $369k TRDA by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.10 | 3,034 | $61K | 16.5% |
| 2 | $20.10 | 3,034 | $61K | 16.5% |
| 3 | $20.97 | 5,414 | $114K | 30.8% |
| 4 | $20.97 | 5,414 | $114K | 30.8% |
| 5 | $21.85 | 900 | $20K | 5.3% |
| Total | $20.72 avg | 17,796 |
| $369K |
| 100% |
| Filing → |
| TRDA | SELL | 2024-09-30 | $14K | — | Filing → |
| TRDA | SELL | 2024-09-10 | $35K | — | Filing → |
| TRDA | SELL | 2024-08-20 | $873K | — | Filing → |